Podcasts about Workup

Differential Diagnosis and Workup of Thoracic Aortic Aneurysm   Guest: Juan M. Bowen, M.D. Host: Malcolm R. Bell, M.D.   Thoracic aortic aneurysms are often found as incidental findings on imaging done for other indications.  In this episode, listeners will learn more about the approach the Mayo Clinic Marfan and Thoracic Aorta Clinic takes. We can often find the cause by taking a directed family history and personal history, by looking for key physical findings, and by obtaining appropriate imaging and often also genetic tests.   Topics Discussed: What is the differential diagnosis in adult patients? What questions are most helpful in the patient history, and what physical findings should the examiner look for? What cardiac and vascular imaging should be done on the initial evaluation? When should genetic tests be considered? When should preventive aortic repair be considered?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 14-January-2026

You were told to try again. Maybe you were told it was bad luck, or to wait until it happened a third time before anyone would look. Here is what changed this year. In 2026, the American Society for Reproductive Medicine updated its definition of recurrent pregnancy loss for the first time since 2012. Two losses now meet the definition, not three, and a positive test that ended early counts. The old number kept women waiting for a third loss before the investigation even started. Here is the part no one tells you. Meeting the definition gets you a workup. It does not guarantee the workup is complete. After two or more losses, up to half of couples are told the same word. Unexplained. The losses are real. What gets called a complete workup is the question. This episode is the 9 specific things we most often find that are rarely checked before a woman is told her losses were unexplained or simply bad luck. Pull it up. Take notes. Bring it to your next appointment. The 9 patterns: Thyroid, the full panel and antibodies, not just TSH Antiphospholipid antibodies, tested correctly Chronic endometritis The reproductive microbiome, vaginal and seminal The gut, hidden gluten, and inflammation Sperm DNA fragmentation The male partner's full bloodwork Blood sugar and metabolic patterns The nervous system and progesterone These are the areas that sit outside a standard miscarriage workup. A 2012 meta-analysis in Human Reproduction, pooling sixteen studies and nearly three thousand couples, found miscarriage rates rose with sperm DNA damage, with about twice the relative risk. Unexplained rarely means there is nothing to find. It usually means the search stopped at the karyotype, one antiphospholipid test, the anatomy, and a TSH. For the full breakdown of every pattern, read the companion article, Recurrent Pregnancy Loss: The Functional Fertility Approach, at https://fabfertile.com/blogs/learn/recurrent-pregnancy-loss WHAT YOUR CLINIC MISSED The companion guide walks through all 9 of these patterns in more detail, so you can take it to your next appointment and ask the questions. Email hello@fabfertile.ca, subject line MISSED, and we will send you the guide. FUNCTIONAL FERTILITY SECOND OPINION A free 45-minute call where I review your labs, your history, your losses, and your partner's results with you. You leave knowing what your biology has been telling you and what your next decision could be. Email hello@fabfertile.ca, subject line FERTILE, or book here. ABOUT THE HOST I'm Sarah Clark, founder of Fab Fertile and host of Get Pregnant Naturally, a podcast with over one million downloads. My functional fertility team works with couples navigating low AMH and failed IVF, reviewing functional lab results, gut microbiome, food sensitivity, vaginal microbiome, nutrigenomics, HTMA, DUTCH, toxin testing, and bloodwork alongside nervous system work, to help identify patterns that may not have been considered. We work alongside your medical team, not instead of them. Sarah Clark, founder of Fab Fertile, host of Get Pregnant Naturally (1M+ downloads), and author of Fabulously Fertile. If this episode helped, leave a review on Apple Podcasts. It is how other women find this work. TIMESTAMPS 00:00 What "Unexplained" Means and What the 2026 Guideline Changed 01:30 Who's Reviewing Your Case at Fab Fertile 04:00 Thyroid: The Full Panel, Not Just TSH 05:50 Antiphospholipid Antibodies, Tested Correctly 06:30 Chronic Endometritis 07:30 The Reproductive Microbiome 08:30 The Gut, Hidden Gluten, and Inflammation 10:30 What Your Clinic Missed Guide 11:00 Sperm DNA Fragmentation 12:30 The Male Partner's Full Bloodwork 13:50 Blood Sugar and Metabolic Patterns 15:20 The Nervous System and Progesterone 16:30 What "Unexplained" Really Means 17:20 The Functional Fertility Second Opinion

For years, an indeterminate thyroid biopsy meant diagnostic surgery but molecular testing is now changing that reality entirely. On this episode of the BackTable ENT podcast, Dr. Ashley Agan interviews endocrinologist Dr. Erik Alexander about how molecular testing and a systematic, layered approach to thyroid nodule evaluation are reducing diagnostic surgeries and enabling more individualized patient care. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by Veracytehttps://www.veracyte.com/ --- Timestamps 00:00 - Introduction02:48 - Incidence, Presentation, and Workup of Thyroid Nodules 06:26 - Hormonal Impact and Indications for FNA 10:49 - FNA workflow and Bethesda Categories 16:10 - Role of Molecular Testing for Indeterminate Nodules19:59 - Evolution of Molecular Testing and Afirma 23:51 - Basics of DNA based Testing and RNA based Testing 28:34 - Comparing DNA based and RNA Based Testing 32:10 - Utility of Molecular Testing and Sampling Techniques 35:55 - Cost Coverage and Practical Limits39:20 - Clinical Implications and Future Impact42:00 - Final Takeaways --- More about this episode Together they walk through the full evaluation pathway, including ultrasound risk stratification using the TI-RADS criteria, the role of TSH testing, and how FNA indications have shifted from biopsying every solid nodule to a more selective, risk-adapted approach. The discussion covers the Bethesda classification system and addresses why the one-third of patients landing in indeterminate categories (Bethesda III, IV, and V) have historically been the most challenging and most overtreated group. The conversation then explores molecular diagnostics as an additional layer of risk assessment, highlighting key differences between DNA-based mutation panels and RNA-based expression classifiers. Dr. Alexander also discusses practical considerations like insurance coverage, sampling technique, turnaround time, and the future potential of molecular testing to move beyond diagnosis toward individualized prognosis. --- Resources American College of Radiology: TI-Rads Guidelines https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/RADS/TI-RADS/TI-RADS-Assessment-Categories.pdf American Thyroid Association - Nodule Guidelineshttps://pmc.ncbi.nlm.nih.gov/articles/PMC4739132/ Bethesda System for Reporting Thyroid Ctyopathology https://www.ncbi.nlm.nih.gov/books/NBK278969/table/thyroid-nod-canc-eld.T.bethesda_system_f/ --- BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Broadcast from KSQD, Santa Cruz on 6-04-2026: A caller with previously normal platelets now bouncing between 40-60 asks whether to accept her doctor's recommendation of high-dose dexamethasone. Dr. Dawn suggests checking homocysteine and methylmalonic acid for hidden B12 issues, getting an ultrasound to rule out splenic sequestration, and confirming actual autoimmune antibody testing before committing to steroids. Researchers invented a fake disease called "Bixonimania" (periorbital hyperpigmentation supposedly caused by blue light) with obvious tells including a fictional Asteria Horizon University and Starfleet Academy acknowledgment. By 2026, AI chatbots were routinely describing it as real, and three Indian researchers even cited the fake preprint in a peer-reviewed paper that was subsequently retracted. A 75-year-old caller asks about intermittent fasting patterns. Dr. Dawn advises against fasting longer than 24 hours after age 75 due to muscle catabolism, and recommends time-restricted eating instead—starting with protein at 10am to prevent muscle breakdown. For rebuilding lost muscle she prescribes resistance bands, 30g protein including 5g branched-chain amino acids before exercise, and total daily protein matching one's age in grams. A male caller with a T-score of -4.0 on DEXA (diagnostic of severe osteoporosis) asks about pulsed electromagnetic frequency therapy for his hip. Dr. Dawn explains bone's piezoelectric properties mean that compression and electrical stimulation both activate osteoblasts. She recommends checking parathyroid hormone (tumors cause silent calcium loss), notes that vitamin D above 10,000 IU daily can paradoxically activate osteoclasts and worsen osteoporosis. She discusses how decades of proton pump inhibitor use cause achlorhydria leading to both B12 deficiency (elevated MCV) and calcium malabsorption. The same caller asks whether AI has genuine empathy after seeing Claude express regret about military use, and Dr. Dawn explains AI is a statistical mirror — the illusion of empathy from frequency-based word selection trained on human text, not genuine feeling. Daraxonrasib, an oral monoclonal drug from Revolution Medicines, doubled survival time in metastatic pancreatic cancer trials from 7 to 13 months, prompting FDA expanded access. Dr. Dawn explains KRAS—the long-elusive target with no binding pockets—was finally tackled using Gregory Verdine's "molecular glue" approach, where small molecules first attach to bystander proteins to create complexes capable of binding KRAS. A high school in San Francisco has seen seven active and 241 latent TB cases since November 2025, with 18% of the school community infected. Dr. Dawn notes California reached a 12-year high of 2,150 TB cases in 2025, and connects the unusually high latent-infection rate to recent Medi-Cal cuts and immigration-related healthcare avoidance. She argues healthcare access for vulnerable populations is a practical disease-prevention measure.

Dr. Drew Carey interviews Dr. Avner Hostovsky on his study evaluating the diagnostic yield of a structured systemic workup in patients presenting with acute visual symptoms who were diagnosed with isolated paracentral acute middle maculopathy (PAMM). From his Ophthalmology article, "High Yield of Systemic Workup in Patients with Acute Isolated Paracentral Acute Middle Maculopathy." Hostovsky A, Peled I, Katz G, et al. High Yield of Systemic Workup in Patients with Acute Isolated Paracentral Acute Middle Maculopathy. Ophthalmology, 2025; 133, 499-505.

Routine doesn't mean risk-free. What should be considered before, during, and after inferior vena cava (IVC) filter placement? In this episode of the BackTable Podcast, interventional radiologist Dr. Daniel O'Neal (Ohio State University) joins guest host Dr. Jessica Yoon to walk through the workup protocols, technical considerations, and multidisciplinary approaches required for placing and following up on IVC filters. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by RADPAD® Radiation Protectionhttps://www.radpad.com/ --- Timestamps 00:00 - Introduction02:10 - IVC Filter Basics07:37 - Workup and Contraindications12:18 - Pre-Procedural Imaging and Timing14:35 - Procedural Technique18:53 - Cavagram and Variant Anatomy23:18 - Filter Positioning and Deployment30:02 - IVC Filter Complications33:58 - Post-Placement Follow-Up39:14 - Final Thoughts and Closing Remarks --- More about this episode The physicians review the key indications for the procedure, highlighting evidence-based patient selection and emphasizing the need for interventional radiologists to critically assess the clinical workup rather than function merely as technicians. They discuss how a comprehensive pre-procedural workup relies on cross-sectional imaging to identify access obstacles and to plan for adequate filter placement in cases of variant anatomy. Dr. O'Neal also shares technical tips from the suite, including deployment mechanics, positioning considerations, and strategies for preventing common complications. The conversation concludes with the IR's ongoing responsibility to ensure a robust, multidisciplinary follow-up system with referring specialties, outlining potential strategies to ensure these devices are safely retrieved in a timely manner when no longer indicated. --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

The donor egg recommendation rarely comes after a complete workup. It comes after AMH, FSH, and an antral follicle count. That is usually where the investigation stops. In this episode, Sarah Clark walks through what is missing from the workup before women are told donor eggs are their only path: the full thyroid panel, not just TSH. Stool DNA testing for H. pylori, parasites, and food sensitivities. The vaginal microbiome. The male partner's blood work, which most clinics do not run. The nervous system patterns most REIs do not connect to fertility. Sarah shares Rebecca's case as a proof point. Rebecca was 27. Her AMH was 0.04 ng/mL. POI diagnosis. Told donor eggs were her only option. Her stool DNA testing revealed H. pylori and a parasite. Her food sensitivity testing showed gluten, dairy, and egg intolerance. She had adrenal insufficiency, thyroid imbalance, mineral depletion, and toxic load on her workup. Her eczema, migraines, and asthma were not separate issues. After targeted work, she conceived naturally in month five. Outcomes vary. Rebecca's case is one of many we use to illustrate what completing the workup can look like. This episode is for the woman sitting with a donor egg recommendation who is not ready to agree before she understands what was actually evaluated. The goal is clarity. Not opposition to your clinic. Not a guarantee of any outcome. Clarity on what your workup did not include, so that whatever you decide next gets made on the full picture. What this episode covers: The diagnosis is real. The investigation is incomplete. Why TSH alone is not a thyroid panel. H. pylori, hidden food sensitivities, and the gut inflammation driver. Eczema, migraines, and asthma as fertility signals. The male partner's workup should include beyond a semen analysis. Nervous system patterns most REIs do not connect to fertility. Next steps: Access the free guide: What Your Clinic Missed. The guide walks through the markers that the Fab Fertile team reviews before a donor egg recommendation. Email hello@fabfertile.ca, subject line MISSED. Book a Functional Fertility Second Opinion. We'll review your labs, your history, your full picture, and your partner's picture together, so you know what your biology has been telling you and what your next decision should be informed by. Email hello@fabfertile.ca, subject line FERTILE, or book here. About the Host I'm Sarah Clark, founder of Fab Fertile and host of Get Pregnant Naturally, a podcast with over one million downloads. My functional fertility team works with couples navigating low AMH and failed IVF, reviewing functional lab results, gut microbiome, food sensitivity, vaginal microbiome, nutrigenomics, HTMA, DUTCH, toxin testing, and bloodwork alongside nervous system work, to help identify patterns that may not have been considered. We work alongside your medical team, not instead of them. Subscribe to Get Pregnant Naturally for weekly episodes on fertility optimization, IVF preparation, and the lab work your doctor probably isn't running. Timestamps [00:00] The Donor Egg Recommendation and the Investigation Underneath It [01:00] The Diagnosis Is Real. The Investigation Is Incomplete. [02:00] Sarah's POI Story and Why Fab Fertile Exists [03:00] Rebecca's Case: POI at 27, AMH 0.04, ng/mL Told Donor Eggs Were Her Only Option [04:00] Functional Lab Testing Before a Donor Egg Decision [05:00] What We Found: H. pylori, Parasites, Food Sensitivities, Adrenal Insufficiency, Thyroid [06:00] Eczema, Migraines, Asthma: Not Separate Issues From Fertility [07:00] Rebecca Conceived Naturally in Month Five [08:00] What Your Clinic Missed: The Markers Before a Donor Egg Recommendation [09:00] Why a Standard REI Workup Cannot Answer Why Your Numbers Are What They Are [10:00] Medical Gaslighting and the Permission to Investigate Further [11:00] The Functional Fertility Second Opinion: How It Works  

Male factor infertility accounts for nearly half of all infertility cases, yet male evaluation is often delayed or overlooked. In this episode of BackTable Urology, Dr. Robert Brannigan joins guest host Dr. Catherine Nam to unpack the 2024 AUA/ASRM Male Infertility Guideline update and discuss how the field is evolving beyond basic semen analysis. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction04:12 - Rationale Behind the Updates09:37 - Concurrent Couple Evaluation15:01 - Diagnosis, Assessment and Evaluation20:33 - Y Chromosome Microdeletion Testing23:54 - Workup for Recurrent Pregnancy Loss33:57 - Pelvic MRI for EDO36:46 - MicroTESE40:15 - Future Research Directions44:09 - Closing Takeaways --- More about this episode They review updated definitions of infertility, challenges with WHO semen reference ranges, and the need for comprehensive male assessment. The discussion also covers sperm DNA fragmentation, recurrent pregnancy loss, the role of pelvic MRI for ejaculatory duct obstruction, micro-TESE for nonobstructive azoospermia, and the latest directions in male infertility research. --- Resources Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data:https://pubmed.ncbi.nlm.nih.gov/26674559/ Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guidelinehttps://www.auanet.org/guidelines-and-quality/guidelines/male-infertility Sixth edition of the World Health Organization laboratory manual of semen analysis: Updates and essential take away for busy clinicianshttps://pmc.ncbi.nlm.nih.gov/articles/PMC10929669/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Tim Clay sits down with Australian oncology luminaries Prof Ben Solomon and A/Prof Malinda Itchins to discuss the rapidly evolving landscape of Anaplastic Lymphoma Kinase (ALK) positive lung cancer. Since its discovery in 2007, treatment for this subset of non-small cell lung cancer (NSCLC) has advanced through four generations of inhibitors, significantly improving survival outcomes for the 400–500 Australians diagnosed annually. (00:00) Welcome and Acknowledgement (00:43) Meet the Expert Guests (01:40) ALK History and Breakthroughs (03:48) Who Gets ALK Lung Cancer (04:57) Workup and Staging Essentials (05:54) Patterns of Spread and Clots (07:24) Second Generation TKIs Standard (09:03) Long Term Toxicities (11:07) Progression Assessment and LAT (12:50) Lorlatinib After Progression (15:46) Lorlatinib First Line Crown Data (17:11) Choosing and Dosing Lorlatinib (20:55) Managing Lorlatinib Side Effects (22:29) Predicting Response and Follow Up (29:30) Next Generation Inhibitors NAL (32:04) Early Stage and Adjuvant TKIs (36:32) Beyond TKIs Chemo and ADCs (39:30) Patient Support and Closing Support TOGAThank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.---------------Connect with TOGAAttend an Event: https://thoraciconcology.org.au/events/Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/Follow UsLinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/X (Twitter): https://x.com/TOGAANZInstagram: https://www.instagram.com/togaanz/YouTube: https://www.youtube.com/@Thoracic_Oncology---------------Acknowledgement of CountryThe Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Imagine your lab report is a novel and your doctor only reads the back cover. Technically accurate, but you miss the whole plot. In today's episode, I'll show you how I read between the lines of so‑called normal labs to understand what your body is really saying about getting and staying pregnant. I'll also walk you through the fertility "ecosystem" I'm always assessing, and I'll share my three‑stage fertility work‑up for both you and your partner that I use with clients so you can see what might be missing from your current approach.  By the end of this episode, you'll see your labs in a completely new light, and you'll walk away with a simple, three‑phase framework you can start using right away to ask better questions, feel more in control of your work‑up, and take clear next steps to get that healthy baby. If you're LOVING this podcast, please follow and leave a rating and review below. PLUS FOLLOW MY INSTAGRAM PAGE HERE FOR BITE SIZED TTC TIPS! Related Episode Links: Download your NEW Fertility Blood Labs Blueprint Guide (eBook) Here Apply for the Labs Only Package Here → Limited Spots Available For full show notes and related links: https://www.naturallynora.ca/blog/184 Need Nora's Support To Get Pregnant? Click here for a collection of Nora's best self paced programs to get & stay pregnant Apply for Private Fertility Coaching with Nora here Grab Your FREE Resources: Just starting your TTC journey? Download my Eat To Get Pregnant Guide  Having trouble getting and staying pregnant? Download my Top 3 Things To Do When You're Not Getting Pregnant Wondering what supplements to take to help you conceive? Download my Fertility Foundations Supplement Guide Please Note: The contents of this podcast are for educational and informational purposes only. The information is not to be interpreted as, or mistaken for, clinical advice. Please consult a medical professional or healthcare provider for medical advice, diagnoses, or treatment.

The embolization playbook is expanding. The question is: are you ready to use it? In this episode of the BackTable MSK Podcast, host Dr. Ally Bahehi joins Dr. Mikin Patel and Dr. Osmad Ahmed from Joint and Vascular Institute in the greater Chicago area to discuss plantar fasciitis embolization; a newer MSK embolization technique, building from concepts and clinical pearls for genicular artery embolization (GAE). --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction01:18 - Ideal Patient for Plantar Fasciitis Embolization02:14 - Workup, Imaging Needs, and the Reality of Insurance Coverage 03:53 - Benefits And Expectations06:05 - Step By Step Procedure Walkthrough11:29 - Pain Relief and Follow-Up Timeline13:46 - GAE Case Setup14:54 - Debating Access Strategy 15:54 - Crash Course in Genicular Artery Anatomy19:08 - Minimalist GAE Toolkit Set-Up22:32 - Time to Inject! The Wrap Up --- Resources Dr. Mikin Patelhttps://jointvascular.com/team/mikin-v-patel-md-mba/ Dr. Osman Ahmedhttps://jointvascular.com/team/osman-ahmed-m-d-fcirse/

When a male patient presents with lower urinary tract symptoms, should you blame the bladder or bust the prostate? In this SUFU-sponsored episode of BackTable Urology, Dr. Benjamin Brucker (NYU) and Dr. Craig Comiter (Stanford) join host Dr. Chris Tenggardjaja (Kaiser Permanente) for a discussion on evaluating and treating male LUTS using a bladder-and-outlet framework. --- This podcast was developed in collaboration with: Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)https://sufuorg.com/home.aspx --- SYNPOSIS Through a case-based approach, they review initial evaluation strategies including symptom history, validated questionnaires, uroflowmetry, post-void residual measurement, and when tools like voiding diaries can help clarify the diagnosis. The conversation then moves to management, outlining a stepwise approach from behavioral interventions and medications to surgical options when symptoms persist. The doctors discuss how prostate anatomy, side effect profiles, and patient priorities guide treatment selection, when urodynamics may add diagnostic clarity, and why addressing outlet obstruction early may help prevent more difficult-to-treat bladder dysfunction over time. --- TIMESTAMPS 00:00 - Introduction06:31 - Workup for Frequency and Nocturia11:41 - When to Use a Voiding Diary19:18 - Behavioral Therapy26:40 - Post-Finasteride Syndrome30:03 - Surgical Options44:41 - Nocturia Counseling47:32 - Botox With Outlet Surgery49:47 - When to Order Urodynamics54:14 - Bladder or Prostate? --- RESOURCES Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)https://sufuorg.com/home

Aposto Ekibi olarak, “Bizleri gelecekte nasıl bir dünya bekliyor?” sorusundan yola çıkan Dönüm Noktası podcastimizde farklı sektörden farklı şirketleri konuk alarak çalıştıkları alanlardaki gelişmelerin hayatımıza nasıl etki edeceğini konuşuyoruz. Türkiye İş Bankası'nın ana destekçisi olduğu Workup Girişimcilik Programı işbirliğiyle girişimleri ağırlıyoruz. En yeni bölümümüzdeki konuğumuz ise Workup girişimlerinden Breathment'ın kurucu ortağı Elçin Can Çavuşoğlu.

Aposto Ekibi olarak, “Bizleri gelecekte nasıl bir dünya bekliyor?” sorusundan yola çıkan Dönüm Noktası podcastimizde farklı sektörden farklı şirketleri konuk alarak çalıştıkları alanlardaki gelişmelerin hayatımıza nasıl etki edeceğini konuşuyoruz. Türkiye İş Bankası'nın ana destekçisi olduğu Workup Girişimcilik Programı işbirliğiyle girişimleri ağırlıyoruz. En yeni bölümümüzdeki konuğumuz ise Workup girişimlerinden Co-One'ın kurucu ortağı Mert Menekşe.

The microhematuria guideline just changed. Here's what clinicians need to know. In this episode of BackTable Urology, Dr. Daniel Barocas (Vanderbilt University) joins host Dr. Ruchika Talwar to break down the 2025 updates to the American Urological Association (AUA) Microhematuria Guideline and why these changes matter in everyday practice. --- SYNPOSIS They walk through the evidence driving the updates, including revised risk stratification and the expanding role of urinary biomarkers. The conversation highlights how these recommendations affect patient evaluation, imaging decisions, and shared decision-making, with an emphasis on balancing cancer detection, patient burden, and responsible use of healthcare resources. --- TIMESTAMPS 00:00 - Introduction01:33 - What Prompted the Guidelines Update?02:59 - Challenges of a Negative Microhematuria Evaluation06:21 - Initial Evaluation Guidelines07:58 - Risk Stratification18:11 - Imaging in Hematuria Workups21:16 - Use of Urinary Biomarkers33:25 - Potential Future Guideline Updates37:17 - Takeaways for Urologists --- RESOURCES AUA/SUFU Microhematuria Guidelinehttps://www.auanet.org/guidelines-and-quality/guidelines/microhematuria

“Bizleri gelecekte nasıl bir dünya bekliyor?” sorusundan yola çıkan Dönüm Noktası podcastimizde farklı sektörden farklı şirketleri konuk alarak çalıştıkları alanlardaki gelişmelerin hayatımıza nasıl etki edeceğini konuşuyoruz. Türkiye İş Bankası'nın ana destekçisi olduğu Workup Girişimcilik Programı işbirliğiyle girişimleri ağırlıyoruz. En yeni bölümümüzdeki konuğumuz ise Workup girişimlerinden WeFarm. Farming as A Service hizmeti ile WeFarm'ın hizmet verdiği bölgelerde, tarla sahiplerinin boş tarlalarını çok yıllık meyve bahçesi veya üzüm bağına dönüştürebiliyor. Bu girişimin sebeplerini, sonuçlarını ve üretim yollarını tartışıyoruz.

Episode 208: Cough Basics (Pidjin English)Written by Ebenezer DadzieYou are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Episode 201: Cough – Revised Version (Host + 1 Resident; Resident speaks Nigerian Pidgin, Host speaks regular English)[Play intro music, start loud, then lower volume under speech, fade out later]HOST 1:[Introduction]Today we're tackling one of the most common complaints in clinic: the cough. Joining me is one of our amazing residents. Doctor, please introduce yourself.RESIDENT:Na Dr. Resident from Rio Bravo. I dey here to gist about cough wey dey disturb plenty patients for area.Segment 1 – Cough BasicsHOST 2:Let's start simple. When a coughing patient walks into the exam room, what is the first step?RESIDENT:First tin na history. You gats ask whether na dry cough or cough wey dey bring sputum, whether e just start or don tey. Whether person get exposure, dust, new medicine—history dey open many doors pass Google.HOST 1:Exactly. And as we know, acute coughs are usually viral, but chronic coughs lasting more than eight weeks can point to asthma, GERD, ACE inhibitor side effects, or more.Segment 2 – Valley FeverHOST 2:And since we're here in Kern County, we have to mention Valley Fever. We see thousands of cases every year, many of them presenting with cough.RESIDENT:True. Valley Fever fit look like pneumonia, bronchitis, or even TB. Patient go come with cough, tiredness, sometimes rash. If person dey work for outside or dey around dusty area, you suppose reason am.Segment 3 – Workup and TreatmentHOST 1:So let's talk evaluation. When you have a cough here in California's Central Valley, what is your approach?RESIDENT:Start from basic: chest X-ray, CBC, ask good history. If e no improve, add Valley Fever blood test. If cough get phlegm, you fit send sputum. If weight dey drop or sweats dey night, you reason TB or cancer. Treatment depend on severity. Mild one fit resolve, but if no be small, na antifungals—like fluconazole—and you go monitor liver enzymes well.Segment 4 – Humor BreakHOST 2:Alright—quick humor break. Got any memorable cough stories?RESIDENT:One man tell me say “doctor, my neighbor ghost na cause my cough.” We check-am finish, na allergy. Ghost no dey push fungus, sha![Both laugh]Segment 5 – TakeawaysHOST 1:Before we wrap up, give listeners top key points on cough.RESIDENT:One—ask better history. Cough dey tell story.Two—if person dey Bakersfield, reason Valley Fever, e fit sneak.Three—no dey give antibiotics anyhow. Virus and fungus no go respond like bacteria.Trivia TimeHOST 2:Trivia question: In adults who don't smoke and aren't on ACE inhibitors, what is the most common cause of chronic cough?A) AsthmaB) GERDC) Chronic bronchitisD) Postnasal drip (Upper airway cough syndrome)RESIDENT:I go choose D—postnasal drip. Na e dey cause that tickle wey no dey go.HOST 1:And that's correct—postnasal drip is the number one cause of chronic cough. Nicely done! You win bragging rights and a cough drop.HOST 2:Thank you for joining us today on Rio Bravo QWeek. To all our listeners—stay curious, keep learning, and if someone sounds like a barking seal in the waiting room, you know it might be more than a cold.HOST & RESIDENT (together):¡Hasta luego![Music fades in, rises, then fades out after 10 seconds]References:Irwin, R. S., & Baumann, M. H. (2018). Chronic cough due to upper airway cough syndrome (UACS): ACCP evidence-based clinical practice guidelines. Chest, 129(1_suppl), 63S–71S. https://doi.org/10.1378/chest.129.1_suppl.63S(Guideline on postnasal drip/upper airway cough syndrome as a leading cause of chronic cough)Dicpinigaitis, P. V. (2022). Evaluation and management of chronic cough. New England Journal of Medicine, 386(16), 1532–1541. https://doi.org/10.1056/NEJMra2115321(Comprehensive review on causes, diagnostic strategies, and treatment of chronic cough)Centers for Disease Control and Prevention. (2023). Coccidioidomycosis (Valley fever) statistics. U.S. Department of Health and Human Services. https://www.cdc.gov/fungal/diseases/coccidioidomycosis/statistics.html(Official CDC data and epidemiology of Valley Fever in the U.S., including high incidence in Kern County)California Department of Public Health. (2022). Coccidioidomycosis in California Provisional Monthly Report. https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/Coccidioidomycosis.aspx(State-level surveillance data showing high incidence rates in Bakersfield and Kern County)Prasad, K. T., & LoSavio, P. S. (2023). Approach to the adult with chronic cough. In UpToDate (L. M. Leung, Ed.). Retrieved June 20, 2025, from https://www.uptodate.com(Evidence-based resource for differential diagnosis and workup of cough in primary care)Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

From asymptomatic dimples to chronic infections—here's how experts navigate the spectrum of preauricular pits. In this episode of the Back Table ENT podcast, pediatric otolaryngologists Dr. Eric Gantwerker and Dr. Eric Berg discuss the surgical management of Preauricular Pits with host Dr. Gopi Shah. --- SYNPOSIS The conversation covers the etiology of preauricular pits, their presentations, decision-making for excision, surgical techniques, post-operative management, recurrence, and valuable tips in preauricular pit management. The doctors also touch upon collaboration with facial plastics and the importance of communication with families. --- TIMESTAMPS 00:00 - Introduction 03:11 - Common Presentations & Management of Preauricular Pits06:17 - Differential Diagnoses and Imaging13:56 - Surgical Considerations and Techniques18:51 - Managing Recurrent Infections19:07 - Skin Flap Techniques19:55 - Excising Chronic Wounds23:07 - Post-Op Management24:46 - Revision Surgery Insights29:08 - Final Tips and Pearls --- RESOURCES Dr. Eric Gantwerker https://www.northwell.edu/find-care/find-a-doctor/dr-eric-alan-gantwerker-md-ms-1144482662 Dr. Eric Berg https://www.wellstar.org/physicians/eric-berg-md

We review BRUEs (Brief Resolved Unexplained Events). Hosts: Ellen Duncan, MD, PhD Noumi Chowdhury, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/BRUE.mp3 Download Leave a Comment Tags: Pediatrics Show Notes What is a BRUE? BRUE stands for Brief Resolved Unexplained Event. It typically affects infants 60 days old Gestational Age: GA > 32 weeks (and Post-Conceptional Age > 45 weeks) Frequency: This is the first episode Duration: Lasted < 1 minute Intervention: No CPR performed by a trained professional Clinical Picture: Reassuring history and physical exam Management for Low Risk: Generally do not require extensive testing or admission. Prioritize safety education/anticipatory guidance. Ensure strict return precautions and close outpatient follow-up (within 24 hours). High Risk Criteria Any infant not meeting the low-risk criteria is automatically High Risk. Additional red flags include: Suspicion of child abuse History of toxin exposure Family history of sudden cardiac death Abnormal physical exam findings (trauma, neuro deficits) Management for High Risk: Requires a more thorough evaluation. Often requires hospital admission. Note: Serious underlying conditions are identified in approx. 4% of high-risk infants. Differential Diagnosis: “THE MISFITS” Mnemonic T – Trauma (Accidental or Non-accidental/Abuse) H – Heart (Congenital heart disease, dysrhythmias) E – Endocrine M – Metabolic (Inborn errors of metabolism) I – Infection (Sepsis, meningitis, pertussis, RSV) S – Seizures F – Formula (Reflux, allergy, aspiration) I – Intestinal Catastrophes (Volvulus, intussusception) T – Toxins (Medications, home exposures) S – Sepsis (Systemic infection) Workup & Diagnostics Step 1: Stabilization ABCs (Airway, Breathing, Circulation) Point-of-care Glucose Cardiorespiratory monitoring Step 2: Diagnostic Testing (For High Risk/Symptomatic Patients) Labs: VBG, CBC, Electrolytes. Imaging: CXR: Evaluate for infection and cardiothymic silhouette. EKG: Evaluate for QT prolongation or dysrhythmias. Neuro: Consider Head CT/MRI and EEG if there are concerns for trauma or seizures. Clinical Pearl: Only ~6% of diagnostic tests contribute meaningfully to the diagnosis. Be judicious—avoid “shotgunning” tests in low-risk patients. Prognosis & Outcomes Recurrence: Approximately 10% (lower than historical ALTE rates of 10-25%). Mortality: < 1%. Nearly always linked to an identifiable cause (abuse, metabolic disorder, severe infection). BRUE vs. SIDS: These are not the same. BRUE: Peaks < 2 months; occurs mostly during the day. SIDS: Peaks 2–4 months; occurs mostly midnight to 6:00 AM. Take-Home Points Diagnosis of Exclusion: You cannot call it a BRUE until you have ruled out obvious causes via history and physical. Strict Criteria: Stick strictly to the Low Risk criteria guidelines. If they miss even one (e.g., age < 60 days), they are High Risk. Education: For low-risk families, the most valuable intervention is reassurance, education, and arranging close follow-up. Systematic Approach: For high-risk infants, use a structured approach (like THE MISFITS) to ensure you don’t miss rare but reversible causes. Read More

Welcome to the Oncology Brothers podcast! In this Challenging Cases episode, we take a deep dive into thrombocytopenia management—a common yet often perplexing topic in everyday hematology and oncology practice. We are joined by Dr. Ronak Mistry, hematologist at the University of Pennsylvania and co‑host of Fellows on Call, to walk through real‑world cases spanning ITP, anticoagulation with low platelets, and HIT. We covered essential topics such as: • Workup of thrombocytopenia and confirming the diagnosis of ITP • First‑ and second‑line ITP therapy—steroids, IVIG, TPO receptor agonists, and splenectomy • ⁠Managing anticoagulation in thrombocytopenic patients with cirrhosis and DVT • ⁠Step‑by‑step approach to suspected HIT in the inpatient setting • Rapid‑fire tips—transfusion thresholds, chemo‑related thrombocytopenia, and medication culprits Whether you're a hematologist, oncologist, or internal medicine resident, this episode is packed with case‑based teaching points, practical pearls, and the latest guidance from ASH and NCCN for non‑malignant hematology. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to like, subscribe, and tune in for more challenging case discussions, treatment strategies, and expert insights from the world of hematology and oncology! #Thrombocytopenia #HematologyPodcast #ITP #HIT #OncologyBrothers

Pastor Mike Prince

“Bizleri gelecekte nasıl bir dünya bekliyor?” sorusundan yola çıkan Dönüm Noktası podcastimizde farklı sektörden farklı şirketleri konuk alarak çalıştıkları alanlardaki gelişmelerin hayatımıza nasıl etki edeceğini konuşuyoruz. Türkiye İş Bankası'nın ana destekçisi olduğu Workup Girişimcilik Programı işbirliğiyle girişimleri ağırlıyoruz. En yeni bölümümüzdeki konuğumuz ise Workup girişimlerinden Deepin'in kurucu ortağı ve CEO'su Çetin Yalçın Güleç. Bu bölümde Çetin Yalçın Güleç ile Deepin'in kuruluş hikâyesi, ajan tabanlı yapay zekâ dünyası, yapay zekâ ajanlarının ne olduğu ve şirket süreçlerini nasıl otonom hale getirdiğini konuştuk. Güleç finans, yatırım ve e-ticaret alanlarında neden yoğunlaştıklarını, sundukları çözümler ve manuel işlerin nasıl hızla ölçeklenebilir hale getirildiğini, Deepin'in vizyon ve hedeflerini anlattı.

"Bizleri gelecekte nasıl bir dünya bekliyor?” sorusundan yola çıkan Dönüm Noktası podcastimizde farklı sektörden farklı şirketleri konuk alarak çalıştıkları alanlardaki gelişmelerin hayatımıza nasıl etki edeceğini konuşuyoruz.Türkiye İş Bankası'nın ana destekçisi olduğu Workup Girişimcilik Programı işbirliğiyle girişimleri ağırlıyoruz. En yeni bölümümüzdeki konuğumuz ise Workup'ın 13. Dönem girişimlerinden Rudiq'in kurucularından Mustafa Kemal Akıllıoğlu.Bu bölümde Rudiq'in kurucu ortağı Mustafa Kemal Akıllıoğlu ile blockchain tabanlı finansal teknolojilerin geleceğini konuştuk. Akıllıoğlu, Rudiq'in gayrimenkulden altına, sanat eserlerinden farklı finansal enstrümanlara kadar pek çok varlığı tokenizasyon yoluyla yatırımcılara açtığını, böylece yatırımın demokratikleşmesine, küresel ölçekte likiditeye erişime ve daha düşük maliyetlerle hızlı işlemlere olanak sağladığını anlattı. Sohbetimizde tokenizasyonun geleneksel finansla nasıl kesiştiği, Türkiye'de ve dünyada regülasyonların sektöre etkileri, Rudiq'in Workup yolculuğu ve bugün Orta Doğu'dan Avrupa'ya, Amerika'dan Asya'ya uzanan büyüme stratejisi öne çıktı.

You've secured the scene and gathered your cause and origin evidence. So who will you include in the litigation?

You've secured the scene and gathered your cause and origin evidence. So who will you include in the litigation? Learn more about your ad choices. Visit megaphone.fm/adchoices

Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies.PresenterPeter Dicpinigaitis, MDProfessor of MedicineAlbert Einstein College of MedicineDivision of Critical Care MedicineMontefiore Medical CenterDirector, Montefiore Cough CenterBronx, New YorkLink to full program:https://bit.ly/4kweynG

How do you assess a product fire case? Follow our analysis and get some key insights as we begin to work up an intake on a tragic hospice bed fire.

How do you assess a product fire case? Follow our analysis and get some key insights as we begin to work up an intake on a tragic hospice bed fire. Learn more about your ad choices. Visit megaphone.fm/adchoices

From acute to chronic conditions, learn how cardiac magnetic resonance imaging (MRI) is a powerful tool for diagnosing heart disease. Credit available for this activity expires: 8/29/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/mri-workup-ischemic-heart-disease-insights-and-innovations-2025a1000man ?ecd=bdc_podcast_libsyn_mscpedu

What piques your clinical suspicion for biliary structure? And when is interventional endoscopy the preferred approach? Fine tune your diagnostic and treatment algorithm with Dr. Premal Trivedi from the University of Colorado and host Dr. Christopher Beck as they go in-depth on the management of biliary strictures.---This podcast is supported by:RADPAD® Radiation Protectionhttps://www.radpad.com/---SYNPOSISThe doctors first break down the signs and clinical picture that alert them to a possible biliary stricture. Dr. Trivedi then explains the steps of his workup and preferred imaging, and also describes his threshold to pursue percutaneous transhepatic cholangiography (PTC), especially in diffuse conditions like primary sclerosing cholangitis. Dr. Trivedi also walks through his procedural steps for PTC and drain placement, covering his best practices and typical intraoperative decision making.Dr. Trivedi then explains the role of angioplasty over the course of longitudinal treatment, balloon choice, and his upper limit of catheter upsizing. The doctors also delve into the role of interventional endoscopy and tackling complications such as bleeding and tube leakage. The conversation offers valuable insights for trainees and practitioners alike, and highlights future advancements in biliary interventions.---TIMESTAMPS00:00 - Introduction06:19 - Approach to Biliary Strictures08:10 - Workup and Imaging for Biliary Strictures20:41 - Accessing the Biliary System27:14 - Crossing the Obstruction: Next Steps33:22 - Endoscopic Evaluation and Its Role47:14 - Complications and Pain Management53:40 - Future of Biliary Management54:55 - Conclusion and Final Thoughts

This week, we drive into the wonderful world of transit memes aboard route #4. Plus, the push to close 76 Avenue to cars, the latest efforts to address noisy vehicles, and the need to repair community league facilities.Here are the relevant links for this episode:Police blotter'Unleashing': Politicians Say Ex-Police Watchdog's Insults Go Too FarTransit loveHow two transit movements take similar routes to highlight positivity in place of negativityWellbeing In Transit : Design JamMay 2011: Leading the Way: LRT Dance Party in Edmonton76 AvenueJanuary 2025: 'Bold' vision for 76 Ave calls for rerouting vehicle trafficCity hall committee recommends Mill Creek bridge replacements, daylighting creekCampaign contributionsVoters told Taproot they want campaign contributions disclosed before the electionNoisy vehiclesJuly 2024: $1,000 tickets haven't stopped noisy vehicles: councillorFebruary 2023: Obnoxiously loud vehicles will be fined $1K following changes to bylaw passed by Edmonton city councilFebruary 2021: Edmonton noisy vehicle enforcement pilot sees mixed resultsCommunity leaguesReport shows community league facilities need $30M by 2028 and $100M by 2035Rapid fireEdmonton mayoral candidate Andrew Knack takes campaign to sidewalk — literallyAlberta to launch anti-speeding campaign following 'deeply concerning' surge in fatal collisions in EdmontonLas Vegas is hurting as tourism drops. Are Canadians behind the Sin City slump?Election projectWhat issues do you care about as you consider who to vote for in the 2025 municipal election, and why?A progress report on Taproot's election projectWhat we heard at our election listening sessionsThis episode is brought to you by Park Power, your friendly, local utilities provider (and title sponsor of Taproot's Regional Roundup). Park Power offers electricity, natural gas, and internet to homes, businesses, and farms throughout Alberta. Learn more at parkpower.ca.This episode is also brought to you by The Workup, a downtown coworking space featuring cozy common areas, adorned with flourishing greenery, which offer a tranquil retreat to unwind or casually collaborate with team members amidst a backdrop of radiant natural sunlight. Learn More ➔Speaking Municipally is produced by Taproot Edmonton, the most reliable source of intelligence about what's happening in the Edmonton region. Through curiosity-driven original stories, tailored and useful newsletters, a comprehensive and innovative events calendar, and thought-provoking podcasts, we inform, connect, and inspire a more vibrant, engaged, and resilient Edmonton region.Sign up to get The Pulse, our weekday news briefing. It's free! ★ Support this podcast ★

How do we integrate biologics into the existing stepwise treatment model for chronic rhinosinusitis with nasal polyps (CRSwNP)? In this episode, Dr. Reena Mehta, an allergist from Uptown Allergy and Asthma in New Orleans, discusses the use of biologics for treating chronic rhinosinusitis with nasal polyps. ---SYNPOSISDr. Mehta elaborates on the common presentations of patients, the role of biologics such as dupilumab and tezepelumab, and the nuances of patient management post-sinus surgery. Dr. Mehta also covers the workup process, the significance of patient comorbidities like asthma and allergies, and the future perspectives on biologic treatments. Practical aspects of biologic therapy, including insurance hurdles, patient compliance, and the effectiveness of various biologics are thoroughly examined.---TIMESTAMPS00:00 - Introduction 02:27 - Understanding Chronic Rhinosinusitis with Nasal Polyps & Presentation05:22 - Workup and Management of Nasal Polyps07:31 - Treatment Options: Steroids and Biologics15:28 - Tezepelumab: A New Tool in the Toolkit25:03 - Side Effects and Safety of Biologics28:59 - Insurance and Approval Challenges36:14 - Long-Term Safety and Efficacy38:47 - Pediatric Considerations and Future Directions41:37 - Collaboration Between ENT and Allergy Specialists45:07 - Conclusion and Final Thoughts---RESOURCESDr. Reena Mehtahttps://uptownallergyasthma.com/allergist-dr-reena-mehta/

Taproot co-founder Karen Unland returns to the show to talk about how we are approaching the 2025 municipal election and the impact we hope to have. We've also got clips from an interview with Coun. Michael Janz about infill.Here are the relevant links for this episode:Karen UnlandKaren on LinkedInSpeaking Municipally: Episode 127Election projectWhat issues do you care about as you consider who to vote for in the 2025 municipal election, and why?A progress report on Taproot's election projectWhat we heard at our election listening sessionsMichael JanzMichael JanzInfill: FAQEdmonton infill debate: city councillor wants to build bigger buildings along LRT routesThis episode is brought to you by The Workup, a downtown coworking space featuring cozy common areas, adorned with flourishing greenery, which offer a tranquil retreat to unwind or casually collaborate with team members amidst a backdrop of radiant natural sunlight. Learn More ➔Speaking Municipally is produced by Taproot Edmonton, the most reliable source of intelligence about what's happening in the Edmonton region. Through curiosity-driven original stories, tailored and useful newsletters, a comprehensive and innovative events calendar, and thought-provoking podcasts, we inform, connect, and inspire a more vibrant, engaged, and resilient Edmonton region.Sign up to get The Pulse, our weekday news briefing. It's free! ★ Support this podcast ★

Dr. Reid Nichols from Nemours joins the show to discuss her recent article on Ponseti treatment of arthrogrypotic clubfeet. The discussion spans numerous foot pathologies including bunions, coalitions, flatfeet, and some stuff you've probably never heard of! The gang is also excited to welcome a new host, Steph Logterman, to the podcast!   Your hosts are Carter Clement (Manning Family Children's in New Orleans), Tyler McDonald (University of South Alabama), Craig Louer (Vanderbilt), and Steph Logterman (Arnold Palmer Hospital for Children). Music by A. A. Aalto.   References:   The 10-Year Functional Outcome of Ponseti Treatment of Idiopathic and Arthrogrypotic Clubfeet With an Age-Matched Control. Church et al. JPO 2025.   Surgical Treatment for Painful Pediatric Pes Planovalgus: How Does Subtalar Extra-articular Screw Arthroereisis Compare to the Standard Technique of Modified Evans Reconstruction? Nasreddine et al. JPO 2025.   Bedside Aspiration for Workup of the Pediatric Septic Hip: Avoid Trips to the OR and Expedited Time to Diagnosis. K Skaggs et al. JPO 2025.   Timing Matters: Challenges in Delayed Surgical Management of Pediatric Humeral Medial Epicondyle Fractures. Lee et al. JPO 2025.

Drs Kaniksha Desai and Caroline Nguyen discuss postpartum thyroiditis, including risk factors, diagnostic workup, and management strategies. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/index/list_15483_0

Today's quick admit episode is a rapid review on the evaluation of vertigo and dizziness in a hospital setting.Visit https://www.pointofcaremedicine.com/inpatient-admission/dizziness-and-vertigo to see the online admission template and follow along.Timestamps00:00 - Intro and Summary02:13 - Admission Checklist02:51 - HPI Intake06:54 - Focused Physical Exam09:06 - Differential Diagnosis09:49 - Initial Workup10:22 - TreatmentRelated ContentDizziness and Vertigo Clinical Review https://www.pointofcaremedicine.com/review-article/dizziness-and-vertigo12 Key Principles for Diagnosing and Managing Dizziness and Vertigo https://www.pointofcaremedicine.com/blog-post/12-key-principles-for-diagnosing-and-managing-vertigo-and-dizziness

Shownotes Who is the ideal candidate for genicular artery embolization (GAE)? In this BackTable Brief, Dr. Osman Ahmed and Dr. Sid Padia share how they work up and select GAE patients. Dr. Padia and Dr. Ahmed discuss the challenges of patient selection in genicular artery embolization, specifically debating the necessity and utility of MRI with contrast. The discussion also explores the pros and cons of femoral vs. pedal access techniques, considering patient characteristics such as BMI and the practicality of these approaches in various clinical settings. Episode Outline 00:00 - Introduction 00:20 - Use of MRI with Contrast in Patient Selection 04:22 - Challenges and Future Directions of MRI in GAE 07:46 - Pros and Cons of Femoral vs. Pedal Access 10:00 - Practical Considerations Resources Dr. Venkatesh, “Kavi”, Krishnasamy, MD https://www.uab.edu/medicine/radiology/faculty/intervent-radiology/profile/krishnasamy  Dr. Osman Ahmed, MD https://bucksbauminstitute.uchicago.edu/bio/osman-ahmed-md/  Dr. Siddarth, “Sid”, Padia, MD https://www.uclahealth.org/providers/siddharth-padia

Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case.PresenterMichael S. Benninger, MDProfessor of Otolaryngology-Head and Neck SurgeryLerner College of MedicineThe Cleveland ClinicPresident, International Association of PhonosurgeryCleveland, OhioLink to full program:https://bit.ly/4kweynG

Host Mikalyn DeFoor, MD Guest interviewee Nicholas A. Apseloff, MD, discussing his review article, “Primary Anterior Cruciate Ligament Injury: Extrinsic and Intrinsic Risk Factors” from the July 1, 2025 issue Article summarized from the July 1, 2025 issue Review article ““FATAL Graft”: A Diagnostic Algorithm for the Workup of Anterior Cruciate Ligament Reconstruction Graft Failure” Articles summarized from the July 15, 2025 issue Two-part series: Review article “Shoulder Arthroplasty: Current Evidence and Techniques on Infection Diagnosis and Treatment” Review article “Shoulder Arthroplasty: Current Evidence and Techniques on Infection Prevention” Follow this link to download these and other articles from the July 1, 2025 issue of JAAOS and the July 15, 2025 issue of JAAOS. The JAAOS Unplugged podcast series is brought to you by the Journal of the American Academy of Orthopaedic Surgeons and the AAOS Resident Assembly.

Granulomatosis with Polyangiitis (GPA) – Recognition and Management in the ED Hosts: Phoebe Draper, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/GPA.mp3 Download Leave a Comment Tags: Rheumatology Show Notes Background A vasculitis affecting small blood vessels causing inflammation and necrosis Affects upper respiratory tract (sinusitis, otitis media, saddle nose deformity), lungs (nodules, alveolar hemorrhage), and kidneys (rapidly progressive glomerulonephritis) Can lead to multi-organ failure, pulmonary hemorrhage, renal failure Red Flag Symptoms: Chronic sinus symptoms Hemoptysis (especially bright red blood) New pulmonary complaints Renal dysfunction Constitutional symptoms (fatigue, weight loss, fever) Workup in the ED: CBC, CMP for anemia and AKI Urinalysis with microscopy (hematuria, RBC casts) Chest imaging (CXR or CT for nodules, cavitary lesions) ANCA testing (not immediately available but important diagnostically) Management: Stable patients: Outpatient workup, urgent rheumatology consult, prednisone 1 mg/kg/day Unstable patients: High-dose IV steroids (methylprednisolone 1 g daily x3 days), consider plasma exchange, cyclophosphamide or rituximab initiation, ICU admission Conditions that Mimic GPA: Goodpasture syndrome (anti-GBM antibodies) TB, fungal infections Lung malignancy Other vasculitides (EGPA, MPA, lupus)

This week on Fat Science, Dr. Emily Cooper, Andrea Taylor, and Mark Wright break down the essentials of a true metabolic workup. This episode moves beyond social media diet trends and digs into the science behind comprehensive lab panels, what they measure, and why they matter for your whole-body health. Dr. Cooper explains how to interpret common and advanced metabolic markers—like blood sugar, insulin, cholesterol, hormone levels, and more—while Andrea and Mark share personal insights into the power of understanding your metabolic baseline. If you're concerned about weight, diabetes, or just want to know your numbers, this episode gives you the knowledge to talk confidently with your healthcare provider.Key Takeaways:A whole-body metabolic approach goes beyond just weight or blood pressure—comprehensive lab work (plus family history) is essential to uncover risks or dysfunction early.Standard blood panels provide useful clues (glucose, cholesterol, liver, kidney, blood pressure), but advanced tests (A1C, lipid particles, hormone levels, inflammation markers) round out the picture.Metabolic dysfunction is driven by factors far deeper than calories in/out—dieting and under-fueling can actually weaken metabolism over time.Medication for metabolic health is not a failure; it's a science-backed intervention. Early and accurate testing allows for better, evidence-based treatment.Don't ignore “borderline” results—addressing issues early is easier and more effective than trying to reverse advanced dysfunction later.Personal Stories & Practical Advice:Andrea recounts her life-changing journey from endless dieting to real answers through complete metabolic testing and individualized treatment.Mark highlights the need for patients to advocate for themselves and ask for more than just the standard panel at annual exams.References:Diet Failure Rate• Mann, T., et al. (2007). "Medicare's search for effective obesity treatments: diets are not the answer." American Psychologist, 62(3), 220-233• Anderson, J. W., et al. (2001). "Long-term weight-loss maintenance: a meta-analysis of US studies." American Journal of Clinical Nutrition, 74(5), 579-584Persistent Metabolic Adaptation• Fothergill, E., et al. (2016). "Persistent metabolic adaptation 6 years after 'The Biggest Loser' competition." Obesity, 24(8), 1612-1619• Rosenbaum, M., & Leibel, R. L. (2010). "Adaptive thermogenesis in humans." International Journal of Obesity, 34(S1), S47-S55Long-Term Hormonal Disruption • Sumithran, P., et al. (2011). "Long-term persistence of hormonal adaptations to weight loss." New England Journal of Medicine, 365(17), 1597-1604• Rosenbaum, M., et al. (2005). "Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight." Journal of Clinical Investigation, 115, 3579-3586Weight Cycling Cardiovascular Risks• Montani, J. P., et al. (2006). "Weight cycling during growth and beyond as a risk factor for later cardiovascular diseases: the 'repeated overshoot' theory." International Journal of Obesity, 30(S4), S58-S66Resources:Connect with Dr. Emily Cooper on LinkedInConnect with Mark Wright on LinkedInConnect with Andrea Taylor on InstagramFat Science is a podcast on a mission to explain where our fat really comes from and why it won't go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn't a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org or dr.c@fatsciencepodcast.comScience is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org

In this 310th episode I welcome Dr. Annemarie Thompson, head of the working group that put out the new AHA/ACC Guidelines for the perioperative cardiovascular management for noncardiac surgery, and Drs. Jochen Steppan and Giancarlo Suffredini, cardiac anesthesiologists, to talk about the new iteration of the guidelines. We go through the algorithm in detail and talk about the evidence behind it and how to use biomarkers. Our Sponsors:* Check out Eko: https://ekohealth.com/ACCRAC* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor: https://factormeals.com/accrac50off* Check out Truelearn and use my code ACCRAC for a great deal: https://truelearn.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Listen as Michael S. Blaiss, MD provides case-based perspectives on chronic cough recognition, burden, management, and pathophysiology and describes the evolving treatment landscape for refractory chronic cough.PresenterMichael S. Blaiss, MDClinical Professor of PediatricsDivision of Allergy-ImmunologyMedical College of Georgia at Augusta UniversityAugusta, GeorgiaLink to full program: https://bit.ly/4kweynG

This episode covers: Cardiology This Week: A concise summary of recent studies Colchicine for secondary prevention An algorithmic approach to the workup of syncope Milestones: CIBIS II Host: Rick Grobbee Guests: Carlos Aguiar, Sanjit Jolly, Michele Brignole Want to watch that episode? Go to: https://esc365.escardio.org/event/1805 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Michele Brignole, Diederick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Sanjit Jolly has declared to have potential conflicts of interest to report: grant support from Boston Scientific, honorarium from Boston Scientific, Shockwave, Abiomed, SIS, and Teleflex.  Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Rick Grobbee Guest: Michele Brignole Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1805?r  Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Michele Brignole, Diederick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

We discuss the injuries sustained from smoke inhalation. Hosts: Sarah Fetterolf, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Smoke_Inhalation.mp3 Download Leave a Comment Tags: Environmental, Toxicology Show Notes Table of Contents 00:37 – Overview of Smoke Inhalation Injury 00:55 – Three Key Pathophysiologic Processes 01:41 – Physical Exam Findings to Watch For 02:12 – Airway Management and Early Intervention 03:23 – Carbon Monoxide Toxicity 04:24 – Workup and Initial Treatment of CO Poisoning 06:14 – Cyanide Toxicity 07:19 – Treatment Options for Cyanide Poisoning 09:12 – Take-Home Points and Clinical Pearls Physiological Effects of Smoke Inhalation: Thermal Injury: Direct upper airway damage from heated air or steam. Leads to swelling, inflammation, and possible airway obstruction. Chemical Irritation: Causes bronchospasm, mucus plugging, and inflammation in the lower airways. Increases capillary permeability, potentially causing pulmonary edema. Systemic Toxicity: Primarily involves carbon monoxide and cyanide poisoning.

This week, we kick off a new, highly-anticipated and highly-requested series, covering venous thromboembolism (VTE). In this first episode, we discuss how we make the initial diagnosis and how we approach initial management. As a clinician, you will undoubtedly come across the need to make this decision. This episode and this series will set you up for success!Episode contents:-What is venous thromboembolism?- How do we diagnose patients with VTE?- How do we initially management patients with VTE? - How do we select anticoagulants for VTE? ****This episode is sponsored by our Global Research Partners! Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss: Workup of COVID-19 in the emergency departmentMethods of COVID-19 risk stratification Treatment recommendations for people with severe COVID-19, including how to effectively use antiviral therapy, dexamethasone, and other immunomodulators[CC1] in this population A detailed patient case to illustrate key takeawaysPresenters:Stephen Cantrill, MD, FACEP​Associate Director and Medical Director (Retired) ​ Department of Emergency Medicine​ Denver Health Medical Center​ Associate Professor ​ Department of Emergency Medicine​ University of Colorado Health Sciences Center​ Denver, Colorado Rajesh T. Gandhi, MD​Massachusetts General Hospital​ Professor of Medicine​ Harvard Medical School​ Boston, Massachusetts Payal K. Patel, MD, MPH, FIDSA​Systemwide Director of Antimicrobial Stewardship​ Associate Professor, Division of Infectious Diseases​ Intermountain Health​ Salt Lake City, Utah Link to full program: https://bit.ly/4gu2gcUGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Dr. Emily Gutowski interviews Dr. Michael Pillinger, NYU rheumatologist and gout expert, about the initial presentation and workup of a patient with this gout. This is the first episode of a two-part series on gout. Join us for the next episode where we'll dive into acute management and long-term outpatient treatment strategies for this chronic condition.

Follow along as the great Dr. Senter guides us through the diagnosis, workup, and treatment of an all-star lineup of sport injuries. Part 1 covers concussions, femoroacetabular  impingement (FAI), and the ongoing quest to diagnose Paul's mysterious hip injury.  Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments 00:00 Introduction  08:43 Case 1 - Concussion  9:39 Approach and Workup of Concussions  18:08 Treatment of Concussions (Return to Activity)  24:10 Consideration of Head Imaging  33:20 Case 2 - Hip Pain (FAI)  34:15 Hip Anatomy and Differential Diagnosis  38:41 Hip Physical Exam  45:41 Hip Imaging  47:28 Treatment of FAI Outro & Take Home Points  Credits Producer and Show Notes: Peter Wikoff MD Writer, Infographic and Cover art: Edison Jyang MD  Reviewer: Sai S Achi MD MBA FACP Hosts and Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP    Technical Production: PodPaste Guest: Dr. Carlin Senter MD Sponsor: ClinicalKey AI ClinicalKey AI is an award-winning solution that combines trusted, evidence-based clinical content with conversational search powered by generative AI. To unlock the power of AI in clinical decision-making with ClinicalKey AI, visit Elsevier.health/AI Sponsor: Freed You can try Freed for free right now by going to freed.ai. And listeners of Curbsiders can use code CURB50 for $50 off their first month. Sponsor: Babbel Get up to 60% off your Babbel subscription - but only for our listeners at Babbel.com/CURB.